Blood & Cancer artwork

Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals

Blood & Cancer

English - August 11, 2020 08:00 - 12 minutes - 23.6 MB - ★★★★★ - 31 ratings
Medicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How I treat multiple myeloma: Dr. Gustavo Fonseca talks triple-agent therapy, transplant, and treatment failure

Next Episode: ISTH 2020: Dr. Hanny Al-Samkari talks VTE in COVID-19, bevacizumab in HHT, and predisposition to thrombosis in NSCLC

Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts

This week in HemOnc news:

Study: Immune checkpoint inhibitors don't increase risk of death in cancer patients with COVID-19: https://bit.ly/2PEttQa System provides 'faster, less invasive' method for breast cancer detection: https://bit.ly/3achral
Source: https://bit.ly/3gN507j FDA approves belantamab in relapsed/refractory multiple myeloma: https://bit.ly/3ksQtQu FDA approves new drug for diffuse large B-cell lymphoma: https://bit.ly/3kvoIXn

For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52

Email the show: [email protected]

Follow Dr. David Henry on Twitter @DavidHenryMD